Maximilian C. Joos

Maximilian C. Joos

Auto-generated profile, based on publicly available information

Maximilian C. Joos

Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Im Neuenheimer Feld 420, 69120 Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2024 in HPB
Verified
Journal Article
Open access
RKRosa Klotz
Rosa Klotz
TPThomas. Moritz Pausch
Thomas. Moritz Pausch
JKJörg Kaiser
Jörg Kaiser
MJMaximilian C. Joos
Maximilian C. Joos
RHRüdiger Hecktor
Rüdiger Hecktor
CKChristoph Kahlert
Christoph Kahlert
Artificial intelligence (AI) offers potential support in patient-clinician interactions, but its impact on such communication remains unexplored. In this study, ChatGPT was compared with two pancreatic surgeons in responding to ten pancreatic cancer surgery-related questions, co-designed with the Patient Advisory Board of the Surgical Society's Study Center. A blind evaluation of these responses, considering content congruency and clarity for non-specialists, was conducted by patients and surgeons. From June 23 to July 21, 2023, 24 patients and 25 surgeons participated, of which eleven patients and ten surgeons completed the survey in full. Utilizing a quantitative scale from 1 (strong-disagreement) to 5 (full-agreement), consensus was observed among patients and specialists concerning the content delivered by ChatGPT. The metrics for comprehensibility to a non-specialist audience consistently showed positive reception. In the evaluation of empathetic resonance, ChatGPT's responses mirrored those of the surgeons in the patient's view. A significant proportion ranked Surgeon 1's contributions foremost, followed closely by ChatGPT. This study demonstrates that surgeons and ChatGPT answer common queries from patients regarding pancreatic cancer surgery comparable regarding reliability, lay comprehension and empathy as evaluated by patients and surgical experts. These findings highlight the potential of AI in enhancing patient-provider interactions.

13 July 2023 in Nature Cardiovascular Research
Verified
Journal Article
Open access
PDF file
BBBastian Bruns
Bastian Bruns
MAMarilena Antoniou
Marilena Antoniou
IBIrena Baier
Irena Baier
MJMaximilian Joos
Maximilian Joos
MSMeryem Sevinchan
Meryem Sevinchan
JBJohannes Backs
Johannes Backs
Takotsubo syndrome (TTS) is an acute heart failure syndrome that mimics the symptoms of acute myocardial infarction and is often preceded by emotional and/or physical stress. There is currently no treatment for TTS. Here we show that injection of 2.5 mg kg−1of epinephrine (EPI) into mice recapitulates numerous features of human TTS, including increased myocardial damage and mortality in males. Gene set enrichment analysis of myocardial RNA sequencing after EPI injection revealed significant enrichment of calcineurin-dependent pro-inflammatory gene networks, which was more pronounced in male than in female mice, in agreement with observed sex discrepancies in the mouse phenotype. An increase in calcineurin activity was detected in the circulating cells of patients with TTS, suggesting a systemic nature of the syndrome. Preventive and therapeutic treatment of mice injected with EPI using calcineurin inhibitors cyclosporine and tacrolimus improved heart function and reduced myocardial injury. Our findings suggest that calcineurin inhibition could be a potential therapy for TTS.

4 March 2023 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
PPPascal Probst
Pascal Probst
DMDaniela C Merz
Daniela C Merz
MJMaximilian C Joos
Maximilian C Joos
AAAzaz Ahmed
Azaz Ahmed
MFManuel Feisst
Manuel Feisst
RKRosa Klotz
Rosa Klotz
Dear Editor

23 January 2026 in eClinicalMedicine
Verified
Journal Article
Open access
GPGeorgios Polychronidis
Georgios Polychronidis
MJMaximilian C. Joos
Maximilian C. Joos
DMDaniela C. Merz
Daniela C. Merz
MHMagdalena Holze
Magdalena Holze
EKEva Kalkum
Eva Kalkum
RKRosa Klotz
Rosa Klotz
With the recent publication of the first randomized controlled trials (RCTs) comparing robotic partial pancreatoduodenectomy (RPD) versus open partial pancreaticoduodenectomy (OPD) now providing high-level evidence, this study aims to analyze the short-term outcomes of RPD versus OPD to answer the ongoing clinical debate regarding the advantages and limitations of RPD, particularly in terms of perioperative safety. We searched Medline, Web of Science, and CENTRAL accessed last on 26th of November 2025 for prospective studies. The main outcome was 90-day mortality; secondary outcomes included complications, and short-term oncological outcomes (R0 resection rate), among others. A random-effects model was employed. Risk of bias was assessed using the Cochrane risk-of-bias-tool (RoB 2) for randomized controlled trials (RCTs), and the ROBINS-I-tool for comparative cohort trials (CCTs). The certainty of evidence was graded according to GRADE. (PROSPERO registration ID: CRD42024523577). Out of a total of 7388 screened studies, 358 studies underwent full-text screening leading to inclusion of 7 studies (3 RCTs and 4 CCTs). No significant difference was observed between RPD and OPD for 90-day mortality [OR (95% CI) 1.07 (0.04, 29.40)], clinically relevant complications including postoperative pancreatic fistula (POPF), or reoperation rates [OR (95% CI) 1.10 (0.47, 2.59)]. Lymph node yield, R0 resection rate, operative time and length of hospital stay were also not significantly different. However, readmission rates favored OPD [OR (95% CI) 1.22 (1.15, 1.28)], while there was a lower amount of intraoperative blood loss in RPD [SMD (95% CI) −0.98 (−1.65, −0.32)]. In this systematic review and meta-analysis, mortality following RPD was comparable to OPD. RPD has demonstrated similar rates for major complications and short-term oncological outcomes and can thus be equally recommended as OPD but this recommendation is limited to experienced, high-volume centers. This systematic review and meta-analysis was investigator-initiated and did not receive additional funding.